Perrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval for its Abbreviated New Drug Application for betamethasone valerate foam, the generic equivalent of Luxiq Foam. Perrigo has manufactured the product and is preparing to begin shipping on January 15, 2013, in line with the launch date.
Perrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval...
Recommended For You
More Trending News
About PRGO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PRGO | - | - |
Perrigo Company plc |